ReleaseWire Connect

As the world turns a corner in the fight against COVID-19 thanks to the approval and mass production of various vaccines, Germany is leading the way with research and development at a crucial stage of the pandemic. With the added pressure of vaccinating as many people as possible to ensure that the transmission of the new variants is kept to a minimum, vaccination capacity needs to be ramped up throughout the country.

The increase in chronic illness rates, such as oncological cancers, asthma, cardiovascular and respiratory conditions, has contributed to an increase in drug consumption. As a result, the demand for new drug and pharmaceutical research has also intensified, making pharmacovigilance careers evermore abundant. Pharmacovigilance has turned into a sector in which billions of people are now intensely relying upon in order to keep the general population safe from adverse and unwanted side effects from medical products such as the coronavirus vaccines.

The turn of the new year brings new hope for the battle against coronavirus. Vaccinations developed in the US and UK by pharmaceutical giants Pfizer/BioNTech and AstraZeneca have proven successful after clinical trials, providing the rest of the world with a light at the end of the tunnel.

Although the development of the new coronavirus vaccines is advancing at an incredible speed, medical professionals in R & D jobs have also been dedicating their focus to discovering medicines and treatments to administer to those who have already been infected with the virus.

In 2019 the total number of adverse events, caused by drugs and medication, which were reported in Europe totaled 60,000, as reported by the European Medicines Agency. This highlights the importance of the pharmacovigilance system in ensuring the safety of patients across the world.

Professionals working in the pharmacovigilance sector play a vital role in tracking adverse events for newly approved drugs. Doctors are expected to relay any information they receive from patients about adverse reactions they have had to their prescribed medication. However, a shocking statistic by the World Health Organisation has stated that roughly 5% of doctors worldwide participate in a pharmacovigilance programme. The sector is hugely important to the safety of German citizens and beyond, roles are currently available in cities across the country from Berlin, to Hamburg, Frankfurt and Cologne. The global market size of the sector is expected to grow at a CAGR of above 12.8% before the end of the decade, according to Acumen Research. This is a promising verdict for individuals looking to progress further in their pharmacovigilance careers in Germany.

Clinical trials are at the top of everyone’s news feeds at the moment with the COVID-19 vaccine being tested across the world. However, clinical trials are vitally important at all points of the year, not only when a global pandemic has occurred.

Managing clinical trials is hugely important to the pharmaceuticals industry. Professionals taking on these roles on a managerial level must be highly organised, reliable and quick-thinking. With more than 300,000 clinical trials happening everyday worldwide, according to a report by the US National Library of Medicine, it is hugely important for these to be done efficiently to produce the most effective results and reduce costs.

Public safety is of the utmost importance for Germany who have largely established themselves as the “world’s pharmacy” due to being home to Europe’s largest pharmaceuticals market, the fourth largest in the world according to a report by Pharma Phorum. Only a small amount of subjects are usually used for clinical trials, despite this many medicinal products are granted a marketing authorisation, this leaves many adverse-events to occur.

Founded in 2012, EPM Scientific are the leading specialist recruiters for the life sciences industry in Germany. Their reach spans the country from Berlin, Hamburg, Munich, Frankfurt and beyond as their consultants work around the clock to provide expert local knowledge on the industry markets and recruitment processes. The firm give life science corporations peace of mind when it comes to their biggest issue: talent acquisition. Germany currently holds centre stage with Europe's largest pharmaceuticals market and the fourth largest in the world, fondly known as 'world's pharmacy'. The country is an exciting place to be to advance your life science career as industry managers are looking for talented new professionals to push the sector forward.